HighTide Therapeutics, Inc. (Stock Code: 02511) submitted a monthly return announcing that, as of October 31, 2025, total authorized share capital stood at US$100,000, with 1,000,000,000 ordinary shares authorized at a par value of US$0.0001 each. There was no increase or decrease in authorized capital during the month.

According to the return, the number of issued shares remained at 571,325,668, and there were no treasury shares. No new share options, warrants, convertibles, or other share issuance arrangements were recorded. The filing confirms that all regulatory conditions have been fulfilled in accordance with applicable listing and legal requirements.